Table 2.

cGMP, NO, H2S bladder and testis values.

		Group	Mean ± SD	Median (%25)–(%75)	p
cGMP	Bladder	C	315.09±79.56	304.30 (243.33)–(378.13)	0.009
		CP	195.70±19.71	196.44 (178.21)–(212.35)**
		NaHS25	221.97±30.31	218.92 (201.67)–(246.83)**
		NaHS50	224.78±37.6	239.34 (190.00)–(255.00)**
		NaHS100	287.62±66.38	295.45 (215.72)–(338.75)++
	Testis	C	23.28±16.22	15.62 (10.62)–(42.14)	0.002
		CP	5.72±2.51	5.35 (4.32)–(7.27)
		NaHS25	18.90±10.59	15.81 (10.82)–(29.23)++
		NaHS50	37.68±15.86	38.30 (22.51)–(52.15)++
		NaHS100	32.83±23.56	26.53 (11.13)–(61.10)++
NO	Bladder	C	24.73±9.48	21.88 (17.54)–(36.09)	0.05
		CP	18.70±3.89	19.09 (14.38)–(22.38)
		NaHS25	25.85±7.16	25.23 (20.50) –(31.67)
		NaHS50	32.15±6.24	31.59 (26.56)–(38.85)*+
		NaHS100	26.21±9.06	25.86 (17.38)–(36.17)*+^
	Testis	C	0.71±0.52	0.71 (0.17)–(1.13)	0.006
		CP	0.46±0.28	0.36 (0.25)–(0.68)
		NaHS25	1.04±0.43	1.04 (0.80)–(1.44)
		NaHS50	1.74±0.48	2.03 (1.13)–(2.07)**++
		NaHS100	0.91±0.45	0.97 (0.42)–(1.30)^^
H2S	Bladder	C	79.04±18.24	76.34 (61.36)-(96.81)	0.019
		CP	60.81±26.03	65.00 (42.05)-(76.67)
		NaHS25	78.93±22.47	79.67 (58.65)-(100.68)
		NaHS50	108.14±37.98	117.69 (77.11)-(134.13)**++
		NaHS100	116.37±20.73	116.59 (95.15)-(138.64)**++
	Testis	C	0.94±0.56	0.92 (0.39)–(1.44)	0.001
		CP	0.64±0.40	0.54 (0.30)–(1.03)
		NaHS25	1.29±0.27	1.18 (1.12)–(1.48)***+++
		NaHS50	1.99±0.35	2.12 (1.64)–(2.29)***+++
		NaHS100	2.43±0.77	2.61 (1.87)–(3.05)***+++

Values are given as mean ± SD and median (%25)–(%75). Differences are given compared to the C group (*), CP group (+), NaHS50 (^). * p < 0.05; ** p < 0.01; *** p < 0.001, + p < 0.05; ++ p < 0.01; +++ p < 0.001, ^ p < 0.05; ^^ p < 0.01.C: control; CP: cyclophosphamide; NaHS: sodium hydrosulfide.